BACKGROUND: Demand for viral load (VL) monitoring is expected to increase; however, implementation of the multifaceted VL testing poses numerous challenges. We report experiences from Médecins Sans Frontiéres (MSF) and partners in the scale-up of HIV VL in collaboration with the Ministry of Health and Child Care (MoHCC) of Zimbabwe. METHODS: A retrospective data review of routine reports from MSF-supported health facilities in Manicaland Province (Zimbabwe) was conducted. These secondary aggregate data were triangulated, and emerging themes of lessons learnt from VL monitoring were shared. RESULTS: A VL testing coverage of 63% (5966/9456) was achieved among the 40 health facilities, together with a switch rate to second-line antiretroviral therapy (ART) of 46.4% (108/233). The key enablers to scaling-up the VL monitoring were well-equipped and supported VL laboratories, the operationalisation of the on-the-job clinical mentoring and systematic weaning off of better performing health facilities. Concerted efforts from different implementing partners and funders in the HIV programme, and close collaboration with MoHCC were pivotal. CONCLUSION: Our experience indicates that clinical mentoring is effective, and resulted in high VL testing coverage and up-skilling primary health care workers in VL monitoring. Attention must be focused on innovations for improving VL result utilisation, especially the identification and management of patients who fail ART.
BACKGROUND: Demand for viral load (VL) monitoring is expected to increase; however, implementation of the multifaceted VL testing poses numerous challenges. We report experiences from Médecins Sans Frontiéres (MSF) and partners in the scale-up of HIV VL in collaboration with the Ministry of Health and Child Care (MoHCC) of Zimbabwe. METHODS: A retrospective data review of routine reports from MSF-supported health facilities in Manicaland Province (Zimbabwe) was conducted. These secondary aggregate data were triangulated, and emerging themes of lessons learnt from VL monitoring were shared. RESULTS: A VL testing coverage of 63% (5966/9456) was achieved among the 40 health facilities, together with a switch rate to second-line antiretroviral therapy (ART) of 46.4% (108/233). The key enablers to scaling-up the VL monitoring were well-equipped and supported VL laboratories, the operationalisation of the on-the-job clinical mentoring and systematic weaning off of better performing health facilities. Concerted efforts from different implementing partners and funders in the HIV programme, and close collaboration with MoHCC were pivotal. CONCLUSION: Our experience indicates that clinical mentoring is effective, and resulted in high VL testing coverage and up-skilling primary health care workers in VL monitoring. Attention must be focused on innovations for improving VL result utilisation, especially the identification and management of patients who fail ART.
Authors: Jienchi Dorward; Richard Lessells; Paul K Drain; Kogieleum Naidoo; Tulio de Oliveira; Yogan Pillay; Salim S Abdool Karim; Nigel Garrett Journal: Lancet HIV Date: 2018-06-05 Impact factor: 12.767
Authors: Suzanne M McCluskey; Yap Boum; Nicholas Musinguzi; Jessica E Haberer; Jeffrey N Martin; Peter W Hunt; Vincent C Marconi; David R Bangsberg; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Trevor Peter; Clement Zeh; Zachary Katz; Ali Elbireer; Bereket Alemayehu; Lara Vojnov; Alex Costa; Naoko Doi; Ilesh Jani Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396
Authors: David Etoori; Iza Ciglenecki; Mpumelelo Ndlangamandla; Celeste G Edwards; Kiran Jobanputra; Munyaradzi Pasipamire; Gugu Maphalala; Chunfu Yang; Inoussa Zabsonre; Serge M Kabore; Javier Goiri; Roger Teck; Bernhard Kerschberger Journal: J Int AIDS Soc Date: 2018-10 Impact factor: 5.396
Authors: Trudy Tholakele Mhlanga; Richard Makurumidze; Bart K M Jacobs; Tom Decroo; Emma Govere; Hilda Bara; Prosper Chonzi; Ngwarai Sithole; Tsitsi Apollo; Wim Van Damme; Simbarashe Rusakaniko; Lutgarde Lynen Journal: AIDS Res Ther Date: 2022-07-09 Impact factor: 2.846
Authors: Mercy T Mutambanengwe-Jacob; Charles C Maponga; K Rivet Amico; Bernard Ngara; Nonhlanhla Yende-Zuma; Tariro D Chawana; Teacler Nematadzira; Justice F Gumbo; Tendayi Goverayi; Petronella Matibe; Bernadette V Malunda; Jim Aizire; Taha E Taha; Mary G Fowler; Lynda Stranix-Chibanda Journal: AIDS Res Treat Date: 2022-09-05